Marietta Investment Partners’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Marietta Investment Partners’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-7,599	Closed	-$250K	–	118
2014 Q2	$250K	Sell	7,599 -99,103	-93%	-$3.39M	0.1%	106
2014 Q1	$3.93M	Sell	106,702 -2,012	-2%	-$73.8K	1.52%	30
2013 Q4	$4.17M	Buy	108,714 +49,428	+83%	+$1.56M	1.52%	30
2013 Q3	$1.62M	Buy	59,286 +42,188	+247%	+$1,000K	0.64%	49
2013 Q2	$359K	Buy	+17,098	New	+$334K	0.16%	99

Other funds holding WX

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Marietta Investment Partners's WX Position: Q3 2014 in Review

Marietta Investment Partners sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q3 2014, closing a stake of 7,599 shares — an estimated $250K sold.

Marietta Investment Partners first reported a position in WX in Q2 2013 and held it in 5 quarters. The position peaked at $4.17M in Q4 2013. 157 funds tracked by Wall St. Rank hold WX as of Q3 2014.

Marietta Investment Partners reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q3 2014 after selling out during the quarter.
Marietta Investment Partners sold 7,599 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q3 2014, an estimated $250K.
Marietta Investment Partners first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 5 quarters.
Marietta Investment Partners's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $4.17M in Q4 2013.
157 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q3 2014.

Based on Marietta Investment Partners's 13F filing for Q3 2014, filed 13 Nov 2014.